BioCentury
ARTICLE | Company News

Aegis Therapeutics, Dauntless Pharmaceuticals deal

August 24, 2015 7:00 AM UTC

Aegis granted Dauntless exclusive, worldwide rights to use its Intravail drug delivery technology with an undisclosed cancer compound. The deal includes an option for three additional products. Aegis ...